Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03992404 | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury | ||
| NCT02207946 | Botulinum Toxin A to Treat Arm Tremor | ||
| NCT04594213 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT01686061 | Blepharospasm Patient Survey for Patients With Blepharospasm | ||
| NCT00872898 | Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism | ||
| NCT00955799 | Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus | ||
| NCT02188277 | Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy | ||
| NCT00541723 | Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles | ||
| NCT00512135 | Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines | ||
| NCT01893411 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy | ||
| NCT00983099 | Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects | ||
| NCT02002884 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy | ||
| NCT03806933 | Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines | ||
| NCT00507637 | Blepharospasm Short Interval | ||
| NCT00770029 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 | ||
| NCT06091020 | A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury | ||
| NCT01910896 | Effectiveness and Safety Study of Overnight Intensive Patch in Scars | ||
| NCT00430963 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines | ||
| NCT02577224 | An RCT of a Patient-initiated Treatment Service for BEB and HFS | ||
| NCT05585398 | A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods | ||
| NCT05884528 | Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia | ||
| NCT01896895 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid | ||
| NCT00430586 | Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines | ||
| NCT01112371 | Contractubex Treatment in Scars After Abdominal Caesarean Section | ||
| NCT01565395 | Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT03119948 | Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis | ||
| NCT03650387 | Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face | ||
| NCT02091739 | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions | ||
| NCT01305187 | Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 | ||
| NCT00405886 | Neramexane for Tinnitus | ||
| NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | ||
| NCT06995287 | Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea | ||
| NCT07486830 | IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction | ||
| NCT00799942 | Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT03256942 | Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation | ||
| NCT01515371 | Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring | ||
| NCT04210258 | Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face | ||
| NCT00465738 | IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity | ||
| NCT07018713 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine | ||
| NCT01109680 | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | ||
| NCT04908423 | Xeomin® and Gait Related Mobility After Stroke | ||
| NCT03986424 | Local Study of Akatinol Memantine in VaD in Russia | ||
| NCT00777803 | NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines | ||
| NCT04792398 | Bruxism Xeomin® Intervention Trial | ||
| NCT01999894 | Open-label Study of Safety and Tolerability of Memantine in Children With Autism | ||
| NCT02462317 | Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment | ||
| NCT00694148 | Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines | ||
| NCT00407030 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia | ||
| NCT00515944 | Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products | ||
| NCT00429520 | Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds |
